Who can prescribe Ozempic? NP vs MD

If you’re considering weight loss medication like Wegovy, Ozempic, or Mounjaro, you might be wondering: Can I get these prescriptions through telehealth, or do I need to visit a doctor’s office in person?

The short answer is yes—in most cases, you can legally obtain GLP-1 weight loss medications through telehealth. But the details matter, especially depending on which state you live in.

This comprehensive guide breaks down federal and state regulations, explains who can prescribe these medications via telemedicine, and helps you understand what to expect from a legitimate telehealth weight loss program.

Understanding Federal Telehealth Rules for Weight Loss Medications

The Ryan Haight Act Doesn’t Apply to GLP-1s

One of the most important things to know is that medications like Wegovy (semaglutide), Ozempic (semaglutide), and Mounjaro (tirzepatide) are not controlled substances. This distinction is critical because federal law—specifically the Ryan Haight Act—only requires an in-person examination before prescribing controlled substances via telehealth.

Since GLP-1 receptor agonists aren’t controlled, there’s no federal requirement for an in-person visit before a licensed provider can prescribe them through telemedicine. This has been the case throughout the pandemic and remains true as of December 2025.

COVID-Era Flexibilities Extended Through 2025

While GLP-1 medications were always eligible for telehealth prescribing, the pandemic brought broader changes that made virtual care more accessible. In November 2024, the DEA and HHS extended temporary telehealth flexibilities for controlled substances (like ADHD medications or certain pain medications) through December 31, 2025.

Though this extension doesn’t directly affect Wegovy or Ozempic, it reflects the federal government’s continued support for telehealth as a permanent fixture in American healthcare. Patients and providers can expect telemedicine to remain a viable option for obesity treatment well into 2026 and beyond.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Requirements: What You Need to Know

While federal law permits telehealth prescribing of GLP-1 medications, state laws add an extra layer of requirements. Some states require initial in-person examinations, periodic follow-ups, or specific documentation before prescribing weight loss drugs—even via telemedicine.

States Requiring an Initial In-Person Exam

Several states mandate that patients undergo an in-person physical examination before starting weight loss medication, even if subsequent visits can be virtual:

• Arkansas: Must perform the first exam in person; one of the strictest telemedicine states in the nation
• Delaware: Requires initial physical exam before tele-prescribing weight-loss medications
• Georgia: In-person exam required prior to telehealth prescriptions (though follow-ups can be virtual)
• Mississippi: State law requires an initial in-person evaluation for weight management therapy
• New Jersey: Comprehensive in-person exam with lab work required before prescribing
• North Dakota: Hands-on initial evaluation expected for weight-loss treatment
• South Carolina: Must examine patient in person first; periodic evaluations also required
• Texas: In-person exam generally expected prior to telehealth prescribing
• Virginia: Requires initial physical exam, lab tests, and personalized diet/exercise plan; follow-up within 30 days mandatory

States with No In-Person Requirement

Many states allow the entire treatment process—from initial evaluation through ongoing management—to happen virtually:

• California
• Connecticut (must include behavioral counseling and diet/exercise plan)
• Florida (requires BMI ≥30 and visits at least every 3 months)
• Illinois
• New York
• Pennsylvania
• Utah
• Washington

These states recognize that a thorough video consultation, combined with patient-reported measurements and appropriate medical history review, can establish the necessary physician-patient relationship for safe prescribing.

Special State Requirements to Watch

Beyond in-person visit mandates, some states impose additional conditions:

Florida requires:

• BMI of 30 or higher
• Follow-up visits at least every 3 months during treatment
• Documentation of patient’s weight management plan

Connecticut mandates:

• Behavioral counseling component
• Documented diet and exercise plan alongside medication

New Jersey has particularly strict standards:

• Extensive initial evaluation (history, physical, labs, psychological screening)
• Informed consent covering all risks
• Personalized treatment plan

Virginia requires:

• Initial physical exam and lab work
• Diet and exercise plan
• Follow-up within 30 days of starting therapy
• Ongoing monitoring at regular intervals

Who Can Prescribe GLP-1 Medications via Telehealth?

Understanding prescriber qualifications helps set realistic expectations for your telehealth experience.

Medical Doctors (MDs and DOs)

All states allow licensed physicians to prescribe Wegovy, Ozempic, and Mounjaro via telehealth, provided they:

• Hold an active medical license in the state where the patient is physically located
• Establish an appropriate patient-provider relationship (usually through live video consultation)
• Follow their state’s standard of care for obesity treatment

Nurse Practitioners (NPs)

Nurse practitioners can prescribe GLP-1 weight loss medications in all 50 states, but the level of independence varies significantly:

Full Independent Practice (34 states + DC as of 2025):States like California, Washington, New York, Arizona, and Utah allow experienced NPs to evaluate patients and prescribe without physician oversight. This autonomy makes telehealth obesity programs more scalable and accessible.

Collaborative/Supervisory Practice:States including Texas, Florida, Pennsylvania, Georgia, and Mississippi require NPs to work under a physician collaboration agreement or supervisory protocol. The NP can still prescribe GLP-1s, but must have an established relationship with an MD or DO.

Recent Expansions:

• Georgia passed legislation in 2024 allowing NPs and PAs to prescribe even Schedule II controlled substances with physician delegation (a significant expansion, though GLP-1s were always permitted)
• Indiana and Michigan enacted full practice authority for NPs in 2024
• Mississippi has pending legislation (2025) to grant NPs independent practice

Physician Assistants (PAs)

PAs can prescribe weight loss medications in every state, typically under a supervising physician’s license. The degree of autonomy varies, but most states allow PAs significant prescriptive authority for non-controlled medications like semaglutide and tirzepatide.

What This Means for Patients

If you connect with a telehealth provider and your consultation is with an NP or PA rather than an MD, this is completely normal and legal—as long as that provider is properly licensed and credentialed in your state. Reputable telehealth platforms like Klarity Health ensure all prescribers meet state requirements and practice within their scope.

What Makes a Telehealth Weight Loss Consultation Legitimate?

Not all online weight loss services operate with the same standards. Here’s what to expect from a compliant, patient-centered telehealth program:

Comprehensive Medical Evaluation

A legitimate telehealth provider will:

• Require you to complete a detailed medical history questionnaire
• Ask about current medications, allergies, and past medical conditions
• Verify your height, weight, and calculate BMI
• Screen for contraindications (thyroid cancer history, pancreatitis, pregnancy plans, etc.)
• Conduct a live video consultation (not just a text-based questionnaire)

Informed Consent and Counseling

Your provider should:

• Explain how the medication works and what to expect
• Discuss common side effects (nausea, GI upset, potential gallstone formation)
• Cover contraindications and warning signs requiring immediate medical attention
• Provide lifestyle counseling on diet and exercise
• Document your understanding and agreement to the treatment plan

Appropriate Clinical Criteria

Reputable telehealth services screen carefully and will only prescribe if you meet medical necessity criteria:

• BMI ≥30 (obesity), or
• BMI ≥27 with weight-related health conditions (type 2 diabetes, hypertension, high cholesterol, sleep apnea)
• Evidence of previous weight loss attempts through lifestyle modification
• No contraindications to GLP-1 therapy

If you’re slightly overweight but don’t meet clinical obesity criteria, ethical providers will recommend diet, exercise, and behavioral support instead of medication.

Ongoing Monitoring and Follow-Up

Safe weight loss treatment requires regular check-ins:

• Initial follow-up: Typically within 2-4 weeks to assess tolerance and side effects
• Ongoing visits: Every 1-3 months to monitor weight loss, adjust dosage, and evaluate continued appropriateness
• Lab work: Periodic metabolic panels, A1C testing (if diabetic), and other monitoring as clinically indicated
• Dose titration: GLP-1 medications start at lower doses and gradually increase to minimize side effects

Many states mandate specific follow-up schedules—for instance, Florida requires at least one visit every 3 months, and Virginia requires a check-in within 30 days of starting treatment.

Red Flags: How to Spot Questionable Telehealth Services

The popularity of medications like Wegovy has unfortunately attracted some bad actors. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions Without Evaluation

If a service promises you’ll get a prescription without a thorough medical assessment, that’s a major red flag. Legitimate providers evaluate each patient individually and sometimes determine medication isn’t appropriate.

Compounded or ‘Generic’ Semaglutide

As of May 2025, the FDA has banned most compounding of semaglutide for weight loss after declaring the shortage over. Be extremely cautious of:

• Services offering ‘compounded Wegovy’ or ‘generic Ozempic’
• Medications from overseas pharmacies
• Significantly cheaper versions that seem too good to be true

These products may not meet FDA safety and efficacy standards. Stick with FDA-approved brand-name medications dispensed by licensed U.S. pharmacies.

No Licensed Provider or Unclear Credentials

Always verify:

• The prescriber’s name, license number, and state of licensure
• That the provider is licensed in your state (where you physically reside)
• The telehealth company’s physical address and contact information

Avoid services that are vague about who will actually be prescribing your medication or that operate without transparent provider information.

Missing Follow-Up or Monitoring

Any telehealth service that prescribes GLP-1 medications but doesn’t schedule regular follow-ups or monitor your progress is operating below the standard of care. These are powerful medications requiring ongoing oversight—not ‘set it and forget it’ prescriptions.

Pressure Tactics or Upselling

Be wary of services that:

• Use high-pressure sales tactics
• Dramatically downplay side effects or risks
• Push you to commit to long-term payment plans upfront
• Offer ‘VIP packages’ or ‘concierge services’ that seem more focused on profit than patient care

How Klarity Health Approaches Telehealth Weight Loss Treatment

At Klarity Health, we’ve built our weight loss program with patient safety, regulatory compliance, and clinical excellence at the forefront.

Our Process

1. Comprehensive IntakeWe collect detailed medical history, current medications, and measurements through a secure online questionnaire—giving your provider the information needed for an informed evaluation.

2. Live Video ConsultationYou’ll meet with a licensed provider (MD, DO, NP, or PA) via video visit. This isn’t a 5-minute chat—it’s a real medical consultation where we discuss your health goals, assess appropriateness for medication, and create a personalized treatment plan.

3. State-Specific ComplianceOur providers are licensed in your state and follow all local requirements—including arranging in-person exams when state law requires them.

4. Transparent PricingWe accept both insurance and offer cash-pay options with upfront pricing. No surprise bills or hidden fees.

5. Ongoing SupportRegular follow-up appointments ensure we’re monitoring your progress, adjusting treatment as needed, and supporting you with lifestyle counseling alongside medication.

Provider Availability

One of the biggest challenges in weight loss treatment is actually getting an appointment. Many traditional medical practices have months-long wait times for new patients seeking obesity management.

Klarity Health offers:

• Fast appointment availability: Often within days, not months
• Flexible scheduling: Evening and weekend appointments to fit your life
• Nationwide reach: Licensed providers in multiple states (AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA)

Understanding Your Medication Options

Let’s break down the three most common GLP-1 medications prescribed via telehealth:

Wegovy (Semaglutide 2.4mg)

FDA Status: Approved specifically for chronic weight management (2021)

Clinical Criteria: BMI ≥30, or BMI ≥27 with weight-related health condition

Dosing: Self-injected once weekly, starting at lower dose and gradually increasing

Expected Results: Average weight loss of 15-20% of body weight over 68 weeks in clinical trials

Telehealth Availability: ✅ Yes—can be prescribed entirely through telehealth in most states (with state-specific requirements observed)

Ozempic (Semaglutide 0.5-1mg)

FDA Status: Approved for Type 2 diabetes; used off-label for weight loss

Clinical Criteria: Same as Wegovy when used off-label; some providers prefer patients have prediabetes or metabolic syndrome

Dosing: Once-weekly injection

Expected Results: Similar to Wegovy (same active ingredient, slightly different dosing protocol)

Telehealth Availability: ✅ Yes—but providers must document off-label use and obtain informed consent

Important Note: Don’t combine Ozempic with Wegovy (both are semaglutide)

Mounjaro (Tirzepatide)

FDA Status: Approved for Type 2 diabetes; obesity-specific version ‘Zepbound’ approved late 2023

Clinical Criteria: BMI ≥30, or BMI ≥27 with comorbidity

Dosing: Once-weekly injection with gradual titration

Expected Results: Studies show average weight loss of 20-25% (may be more effective than semaglutide for some patients)

Telehealth Availability: ✅ Yes—increasingly prescribed via telehealth for weight management

Medication Comparison: Which Is Right for You?

Your telehealth provider will help determine which medication is most appropriate based on your medical history, insurance coverage, and treatment goals.

What About Compounded Semaglutide?

You may have seen advertisements for ‘compounded semaglutide’ at significantly lower prices than brand-name Wegovy or Ozempic. Here’s what you need to know:

FDA Crackdown in 2025

In May 2025, the FDA declared the semaglutide shortage over and ended the emergency exemption that allowed widespread compounding. Effective immediately, pharmacies can only compound semaglutide in very limited circumstances (such as for patients with specific allergies to inactive ingredients in the commercial product).

Why This Matters

Compounded medications don’t undergo the same rigorous FDA approval process as brand-name drugs. Quality control, potency, and sterility can vary. Several telehealth companies that relied on compounded semaglutide—like Hims & Hers—had to discontinue their programs and lay off staff after the FDA ban.

Bottom Line

Stick with FDA-approved brand-name medications (Wegovy, Ozempic, Mounjaro/Zepbound) dispensed by licensed U.S. pharmacies. While they’re more expensive, you’re getting a medication with proven quality, safety, and efficacy.

Insurance Coverage and Cost Considerations

Insurance Coverage

Coverage for GLP-1 weight loss medications varies widely:

Medicare: Does not cover weight loss drugs (federal law prohibition), but covers Ozempic/Mounjaro for diabetes

Medicaid: Varies by state; some states cover weight loss medications, others don’t

Private Insurance: Increasingly covering these medications, especially for patients with obesity-related comorbidities. Many plans require:

• Prior authorization
• Documentation of previous weight loss attempts
• BMI above certain threshold
• Regular follow-up appointments

Cash-Pay Options

If insurance doesn’t cover your medication, cash-pay options include:

Manufacturer Savings Programs:

• Novo Nordisk (Wegovy/Ozempic) and Eli Lilly (Mounjaro) offer savings cards for eligible patients
• Can reduce monthly costs to $25-$500 depending on insurance status

Telehealth Cash-Pay Programs:

• Some telehealth services negotiate directly with pharmacies for better pricing
• Klarity Health offers transparent cash-pay pricing for patients without insurance coverage

Typical Monthly Costs:

• With insurance: $25-$200 copay
• With manufacturer coupon: $25-$500
• Full cash price: $900-$1,500

State Privacy Laws and Your Telehealth Data

Weight loss is sensitive and personal. When you share information with a telehealth provider, you want to know it’s protected.

HIPAA Still Applies

All legitimate telehealth providers must comply with HIPAA (Health Insurance Portability and Accountability Act), which protects your medical information from unauthorized disclosure.

State Privacy Laws Add Extra Protection

Several states have enacted additional privacy protections beyond HIPAA:

Washington’s My Health My Data Act (2023) requires extra safeguards for health data collected by apps and digital health companies—particularly important given the sensitive nature of weight-loss treatment.

California Consumer Privacy Act (CCPA) gives patients rights over their personal information, including health data collected digitally.

These state laws mean telehealth providers must:

• Obtain explicit consent before collecting health data
• Explain how your information will be used
• Give you control over marketing communications
• Implement strong security measures

Looking Ahead: The Future of Telehealth Weight Loss Treatment

Federal Legislation in Progress

The bipartisan TREATS Act (reintroduced October 2025) aims to make certain telehealth prescribing flexibilities permanent. While focused primarily on addiction treatment and mental health, its passage would signal strong Congressional support for expanded telemedicine access.

Potential DEA Extension for 2026

The current federal telehealth flexibilities for controlled substances expire December 31, 2025. Signs point to a fourth extension or new permanent rules in 2026, but as of December 2025, nothing is finalized. This doesn’t affect GLP-1 medications, but it reflects the broader trajectory toward permanent telehealth expansion.

State-Level Momentum

Multiple states are considering legislation to:

• Grant nurse practitioners full independent practice authority (expanding provider availability)
• Streamline telehealth licensing requirements
• Mandate insurance coverage for obesity treatment
• Reduce barriers to virtual care

The overall trend is clear: telehealth for weight loss is becoming more accessible, not less.

Frequently Asked Questions

Do I need an in-person visit to get Wegovy or Ozempic through telehealth?

It depends on your state. States like California, New York, Illinois, and Washington allow the entire treatment process to happen virtually. However, states including Arkansas, Georgia, New Jersey, Texas, and Virginia require an initial in-person examination. Check the state-specific table in this article for your location.

Can a nurse practitioner prescribe weight loss medications via telehealth?

Yes. Nurse practitioners can prescribe GLP-1 weight loss medications in all 50 states via telehealth. In about 34 states (plus DC), NPs have full independent practice authority. In other states, they work under physician collaboration agreements but still have prescriptive authority for these medications.

Is it safe to get weight loss medication through telehealth?

Yes, when done properly. A legitimate telehealth provider will conduct a comprehensive medical evaluation, discuss risks and benefits, monitor you regularly, and ensure you meet clinical criteria for treatment. The key is choosing a reputable service that follows all state and federal regulations—like Klarity Health.

How much does telehealth weight loss treatment cost?

Costs vary widely:

• With insurance: $25-$200/month copay for medication, plus telehealth visit costs
• Cash-pay: $900-$1,500/month for medication; telehealth consultation fees typically $50-$200 per visit
• With manufacturer savings programs: Can reduce costs to $25-$500/month

Klarity Health offers transparent pricing for both insurance and cash-pay patients, so you know costs upfront.

What if I move to a different state during treatment?

Your telehealth provider must be licensed in the state where you’re physically located. If you move, you’ll need to transition care to a provider licensed in your new state. Some larger telehealth platforms (including Klarity Health) have providers in multiple states and can facilitate this transition.

Can I use telehealth if I live in a rural area?

Absolutely. Telehealth is particularly valuable for patients in rural or underserved areas where obesity medicine specialists are scarce. As long as you have internet access for video consultations, you can receive the same quality care as patients in major cities.

What happens if I experience side effects?

Your telehealth provider should give you clear instructions on managing common side effects and when to seek immediate medical attention. Most platforms offer messaging or urgent consultation options between scheduled appointments. Severe side effects (like signs of pancreatitis or gallbladder problems) require in-person emergency evaluation.

Are compounded versions of semaglutide legal?

As of May 2025, the FDA has severely restricted compounding of semaglutide. Most compounded versions are no longer legal to prescribe or dispense. Stick with FDA-approved brand-name medications from licensed pharmacies.

Take the Next Step Toward Your Weight Loss Goals

If you’ve been struggling with obesity and haven’t found success with diet and exercise alone, GLP-1 medications prescribed through telehealth might be the solution you’ve been looking for.

The good news? Access to these life-changing treatments is better than ever. Telehealth has removed many of the traditional barriers—long wait times, geographic limitations, and the hassle of frequent in-person visits—while maintaining the high standards of care you deserve.

Why Choose Klarity Health for Your Weight Loss Journey

At Klarity Health, we make the process simple:

✅ Fast appointment availability – Often within days, not months
✅ Licensed providers in your state – We follow all state-specific requirements
✅ Transparent pricing – Accept insurance and offer clear cash-pay options
✅ Comprehensive care – From initial evaluation through ongoing support
✅ Convenient virtual visits – No need to take time off work or arrange childcare

Ready to get started? Book a consultation with a Klarity Health provider today. We’ll evaluate your individual situation, discuss whether weight loss medication is right for you, and create a personalized treatment plan that fits your life.

Your weight loss journey deserves expert guidance, convenience, and care that meets you where you are—literally. Let Klarity Health be your partner in achieving lasting, healthy weight loss.

Research Currency Statement

Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)
Sources newer than 2024: 15 of 18 sources (most sources are 2024–2025; older sources used only for baseline context)

⚠️ Flagged for follow-up: Federal telehealth rules for controlled substances are temporary (set to expire 12/31/2025) – an additional extension or new rule is expected. State laws are constantly evolving; watch for any changes in 2026 (e.g., pending NP practice authority bills in states like PA & MS, potential federal legislation like the TREATS Act). Also, FDA oversight on compounded GLP-1 medications tightened in 2025 – ensure compliance with current FDA guidance.

References

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – U.S. Drug Enforcement Administration, November 15, 2024. www.dea.gov

2. COVID-era telehealth prescribing extended for Adderall and other controlled substances – Axios, November 18, 2024. www.axios.com

3. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025 – McDermott Will & Emery, November 18, 2024. www.mwe.com

4. Changing Regulatory and Reimbursement Landscape for Weight Loss Drugs – Goodwin Procter LLP, March 27, 2024. www.goodwinlaw.com

5. Hims to cut 4% of workforce amid ban on weight loss drug copies – Reuters, May 30, 2025. www.reuters.com

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid